(Q53385070)

13 May 2018

http://europepmc.org/abstract/MED/26258989

title

Complement activation product C4d in oral and oropharyngeal squamous cell carcinoma. (English)

1 reference

13 May 2018

http://europepmc.org/abstract/MED/26258989

author

Eloisa Jantus Lewintre

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26258989%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Carlos Camps

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26258989%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Ruben Pio

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26258989%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Juan Pablo Rodrigo

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26258989%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Luis Montuenga

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26258989%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

author name string

D Ajona

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26258989%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

M J Pajares

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26258989%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

M D Chiara

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26258989%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

C Suarez

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26258989%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

J V Bagán

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26258989%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

publication date

7 September 2015

1 reference

13 May 2018

http://europepmc.org/abstract/MED/26258989

published in

Oral Diseases

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26258989%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26258989%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26258989%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

page(s)

899-904

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26258989%20AND%20SRC:MED&resulttype=core&format=json

Investigation of complement activation product c4d as a diagnostic and prognostic biomarker for lung cancer.

31 May 2020

cites work

1 reference

Elevated levels of the complement activation product C4d in bronchial fluids for the diagnosis of lung cancer.

21 January 2018

1 reference

Methylation as a biomarker for head and neck cancer

21 January 2018

1 reference

Oral cancer: clinical features

21 January 2018

1 reference

Tongue cancer: Is there a difference in survival compared with other subsites in the oral cavity?

21 January 2018

1 reference

Ascitic complement system in ovarian cancer

21 January 2018

1 reference

Antibodies reactive to cleaved sites in complement proteins enable highly specific measurement of soluble markers of complement activation

21 January 2018

1 reference

Salivary and serum interleukin 1 beta, interleukin 6 and tumor necrosis factor alpha in patients with leukoplakia and oral cancer

21 January 2018

1 reference

Overexpression of focal adhesion kinase in head and neck squamous cell carcinoma is independent of fak gene copy number.

21 January 2018

1 reference

Involvement of focal adhesion kinase in cellular invasion of head and neck squamous cell carcinomas via regulation of MMP-2 expression.

21 January 2018

1 reference

A review of research on salivary biomarkers for oral cancer detection

21 January 2018

1 reference

Anaphylatoxin C5a creates a favorable microenvironment for lung cancer progression.

21 January 2018

1 reference

Complement and periodontitis.

21 January 2018

1 reference

Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin

21 January 2018

1 reference

Salivary proteomics for oral cancer biomarker discovery

21 January 2018

1 reference

Quantitative proteomics reveals myosin and actin as promising saliva biomarkers for distinguishing pre-malignant and malignant oral lesions

21 January 2018

1 reference

The complement receptors CD46, CD55 and CD59 are regulated by the tumour microenvironment of head and neck cancer to facilitate escape of complement attack

21 January 2018

1 reference

Screening for oral premalignancy and cancer: what platform and which biomarkers?

21 January 2018

1 reference

Exploiting salivary miR-31 as a clinical biomarker of oral squamous cell carcinoma.

21 January 2018

1 reference

Identification of head and neck squamous cell carcinoma biomarker candidates through proteomic analysis of cancer cell secretome.

21 January 2018

1 reference

Modulation of the antitumor immune response by complement

21 January 2018

1 reference

Role of HERG1 potassium channel in both malignant transformation and disease progression in head and neck carcinomas.

21 January 2018

1 reference

Enhancement of human cancer cell motility and invasiveness by anaphylatoxin C5a via aberrantly expressed C5a receptor (CD88).

21 January 2018

1 reference

Genetic and pharmacologic inhibition of complement impairs endothelial cell function and ablates ovarian cancer neovascularization

21 January 2018

1 reference

Expression of tumor-derived vascular endothelial growth factor and its receptors is associated with outcome in early squamous cell carcinoma of the lung

21 January 2018

1 reference

Does the immune system see tumors as foreign or self?

21 January 2018

1 reference

Salivary microRNA: discovery, characterization, and clinical utility for oral cancer detection

21 January 2018

1 reference

The role of complement in tumor growth

21 January 2018

1 reference

Clinical significance of head and neck squamous cell cancer biomarkers.

21 January 2018

1 reference

Chemokines and cytokines as salivary biomarkers for the early diagnosis of oral cancer

21 January 2018

1 reference

Expression of complement restriction factors (CD46, CD55 & CD59) in head and neck squamous cell carcinomas

21 January 2018

1 reference

Complement: a key system for immune surveillance and homeostasis

21 January 2018

1 reference

Time trends in the prevalence of HPV in oropharyngeal squamous cell carcinomas in northern Spain (1990-2009).

21 January 2018

1 reference

Complement c5a receptor facilitates cancer metastasis by altering T-cell responses in the metastatic niche

21 January 2018

1 reference

Choline phosphate cytidylyltransferase-α is a novel antigen detected by the anti-ERCC1 antibody 8F1 with biomarker value in patients with lung and head and neck squamous cell carcinomas

21 January 2018

1 reference

Potentially malignant disorders of the oral and oropharyngeal mucosa; present concepts of management

21 January 2018

1 reference

Diversity in intrinsic strengths of the human complement system: serum C4 protein concentrations correlate with C4 gene size and polygenic variations, hemolytic activities, and body mass index

21 January 2018

1 reference

Increased activity of the mannan-binding lectin complement activation pathway in patients with colorectal cancer.

21 January 2018

1 reference

Salivary mRNA targets for cancer diagnostics

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/ODI.12363

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26258989%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

1 reference